Experimental treatment of patients with disseminated malignant melanoma
Malignant melanoma (MM) is the deadliest skin cancer with an ever-increasing incidence. New treatments have improved the prognosis for patients with advanced MM. Still, most patients do not respond, and the side effects can be severe, underlining the need for better therapies. The overall aim of thi...
Main Author: | Schiza, Aglaia |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Experimentell och klinisk onkologi
2017
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-330710 http://nbn-resolving.de/urn:isbn:978-91-513-0107-5 |
Similar Items
-
Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
by: A. Schiza, et al.
Published: (2017-04-01) -
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up
by: Sara Saellstrom, et al.
Published: (2021-07-01) -
By what way Physician can Enhance Outcomes in Patients with metastatic Malignant Melanoma
by: Mmohammad Erfan Zare, et al.
Published: (2012-01-01) -
By what way Physician can Enhance Outcomes in Patients with metastatic Malignant Melanoma
by: Mehrdad Payandeh, et al.
Published: (2012-03-01) -
Metastatic melanoma and vemurafenib: novel approaches
by: Ramon Andrade De Mello
Published: (2012-04-01)